Skip to Content
Merck
CN
All Photos(1)

Key Documents

Safety Information

AB9303

Sigma-Aldrich

Anti-Trace Amine Receptor 1 Antibody

Chemicon®, from rabbit

Synonym(s):

TA1, TAAR1

Sign Into View Organizational & Contract Pricing

Select a Size

2 G
¥1,429.29

¥1,429.29


Estimated to ship on2025年9月01日Details


Request a Bulk Order

Select a Size

Change View
2 G
¥1,429.29

About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

¥1,429.29


Estimated to ship on2025年9月01日Details


Request a Bulk Order

biological source

rabbit

Quality Level

conjugate

unconjugated

antibody form

affinity purified immunoglobulin

antibody product type

primary antibodies

clone

polyclonal

purified by

affinity chromatography

species reactivity

rat, human, monkey

manufacturer/tradename

Chemicon®

technique(s)

immunohistochemistry: suitable (paraffin)
western blot: suitable

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
615595490865490199
assay

99% (CP)

assay

-

assay

99% (CP)

assay

-

isotopic purity

99 atom % 13C

isotopic purity

98 atom % D

isotopic purity

99 atom % 13C

isotopic purity

99 atom % 13C

mass shift

M+2

mass shift

M+2

mass shift

M+2

mass shift

M+2

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

200

form

solid

form

solid

form

solid

form

solid

mp

137-140 °C (lit.)

mp

137-140 °C (lit.)

mp

52-54 °C (lit.)

mp

132-135 °C (dec.) (lit.)

Specificity

Recognizes Trace Amine Receptor 1 [TAAR1, TA1].
The immunogen has 63% similarity with mouse.

Immunogen

Synthetic peptide from the 3rd cytoplasmic domain of human Trace Amine Receptor 1.

Application

Anti-Trace Amine Receptor 1 Antibody detects level of Trace Amine Receptor 1 & has been published & validated for use in IH(P) & WB.
Immunohistochemistry on paraffin embedded tissue sections.

Western blot.

Optimal working dilutions must be determined by the end user.

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

新产品

  • Certificates of Analysis (COA)

    Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

    Select a Product Number

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Kamonpan Sanachai et al.
    RSC medicinal chemistry, 12(3), 430-438 (2021-05-29)
    The Janus kinase (JAK) and epidermal growth factor receptor (EGFR) have been considered as potential targets for cancer therapy due to their role in regulating proliferation and survival of cancer cells. In the present study, the aromatic alkyl-amino analogs of
    Kamonpan Sanachai et al.
    ACS omega, 7(37), 33548-33559 (2022-09-27)
    Janus kinases (JAKs) are nonreceptor protein tyrosine kinases that play a role in a broad range of cell signaling. JAK2 and JAK3 have been involved in the pathogenesis of common lymphoid-derived diseases and leukemia cancer. Thus, inhibition of both JAK2
    Kamonpan Sanachai et al.
    ACS omega, 7(37), 33587-33598 (2022-09-27)
    Janus kinases (JAKs) are involved in a wide variety of cell signaling associated with T-cell and B-cell mediated diseases. The pathogenesis of common lymphoid-derived diseases and leukemia cancer has been implicated in JAK2 and JAK3. Therefore, to decrease the risk
    Kamonpan Sanachai et al.
    ACS omega, 5(1), 369-377 (2020-01-21)
    Janus kinases (JAKs) are enzymes involved in signaling pathways that affect hematopoiesis and immune cell functions. JAK1, JAK2, and JAK3 play different roles in numerous diseases of the immune system and have also been considered as potential targets for cancer
    Chalita Washington et al.
    PLoS genetics, 16(6), e1008715-e1008715 (2020-06-20)
    Dysregulation of the Ras oncogene in development causes developmental disorders, "Rasopathies," whereas mutational activation or amplification of Ras in differentiated tissues causes cancer. Rabex-5 (also called RabGEF1) inhibits Ras by promoting Ras mono- and di-ubiquitination. We report here that Rabex-5-mediated

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service